CR20110701A - Derivados de pirazoles, su preparacion y su aplicacion terapeutica. - Google Patents

Derivados de pirazoles, su preparacion y su aplicacion terapeutica.

Info

Publication number
CR20110701A
CR20110701A CR20110701A CR20110701A CR20110701A CR 20110701 A CR20110701 A CR 20110701A CR 20110701 A CR20110701 A CR 20110701A CR 20110701 A CR20110701 A CR 20110701A CR 20110701 A CR20110701 A CR 20110701A
Authority
CR
Costa Rica
Prior art keywords
preparation
pirazoles
derivados
therapeutic application
therapeutic
Prior art date
Application number
CR20110701A
Other languages
English (en)
Inventor
Pierre-Yves Abecassis
Pascal Desmazeau
Michel Tabart
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CR20110701A publication Critical patent/CR20110701A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de pirazoles, a su preparación y a su aplicación terapéutica.
CR20110701A 2009-07-03 2011-12-21 Derivados de pirazoles, su preparacion y su aplicacion terapeutica. CR20110701A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903270A FR2947546B1 (fr) 2009-07-03 2009-07-03 Derives de pyrazoles, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CR20110701A true CR20110701A (es) 2012-03-06

Family

ID=41695643

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110701A CR20110701A (es) 2009-07-03 2011-12-21 Derivados de pirazoles, su preparacion y su aplicacion terapeutica.

Country Status (30)

Country Link
US (1) US8367715B2 (es)
EP (1) EP2448924B1 (es)
JP (1) JP5680640B2 (es)
KR (1) KR20120037967A (es)
CN (1) CN102471280B (es)
AR (1) AR077371A1 (es)
AU (1) AU2010267824A1 (es)
BR (1) BR112012000104A2 (es)
CA (1) CA2767096A1 (es)
CL (1) CL2012000013A1 (es)
CO (1) CO6480992A2 (es)
CR (1) CR20110701A (es)
DO (1) DOP2012000001A (es)
EA (1) EA020364B1 (es)
EC (2) ECSP12011569A (es)
FR (1) FR2947546B1 (es)
IL (1) IL217300A0 (es)
MA (1) MA33500B1 (es)
MX (1) MX2012000267A (es)
MY (1) MY155829A (es)
NI (1) NI201200001A (es)
NZ (1) NZ597578A (es)
PE (1) PE20120917A1 (es)
SG (1) SG177463A1 (es)
TN (1) TN2011000658A1 (es)
TW (1) TWI471312B (es)
UA (1) UA106500C2 (es)
UY (1) UY32757A (es)
WO (1) WO2011001122A2 (es)
ZA (1) ZA201200027B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
EP2802324A4 (en) * 2012-01-09 2015-07-15 X Rx Inc BENZHYDROL-PYRAZOLE DERIVATIVES WITH KINASE-INHIBITORY EFFECT AND USES THEREOF
AR094812A1 (es) 2013-02-20 2015-08-26 Eisai R&D Man Co Ltd Derivado de piridina monocíclico como inhibidor del fgfr
WO2016027781A1 (ja) 2014-08-18 2016-02-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 単環ピリジン誘導体の塩およびその結晶
CN114984013A (zh) 2015-03-25 2022-09-02 国立癌症研究中心 胆管癌治疗剂
AU2016374441B2 (en) 2015-12-17 2021-10-21 Eisai R&D Management Co., Ltd. Therapeutic agent for breast cancer
CN107619388A (zh) * 2016-07-13 2018-01-23 南京天印健华医药科技有限公司 作为fgfr抑制剂的杂环化合物
CN107840842A (zh) 2016-09-19 2018-03-27 北京天诚医药科技有限公司 炔代杂环化合物、其制备方法及其在医药学上的应用
BR112020017922A2 (pt) 2018-03-28 2020-12-22 Eisai R&D Management Co., Ltd. Agente terapêutico para carcinoma hepatocelular

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331541B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
GB0317127D0 (en) * 2003-07-22 2003-08-27 Astex Technology Ltd Pharmaceutical compounds
WO2006077425A1 (en) * 2005-01-21 2006-07-27 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors and further antitumor agents
BRPI0619146A2 (pt) * 2005-12-02 2011-09-13 Bayer Pharmaceuticals Corp derivados de 4-amino-pirroltriazina substituìda úteis no tratamento de disordens e doenças hiperproliferativas associadas com angiogênesis
WO2007075377A2 (en) * 2005-12-15 2007-07-05 Cytokinetics, Inc. Certain chemical entities, compositions and methods
US20070208000A1 (en) * 2005-12-15 2007-09-06 Morgan Bradley P Certain chemical entities, compositions and methods
FR2908409B1 (fr) * 2006-11-10 2009-01-09 Sanofi Aventis Sa Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
KR20090092317A (ko) * 2006-12-11 2009-08-31 아이알엠 엘엘씨 키나제 억제제로서의 화합물 및 조성물

Also Published As

Publication number Publication date
SG177463A1 (en) 2012-02-28
DOP2012000001A (es) 2012-01-31
WO2011001122A3 (fr) 2011-02-24
NZ597578A (en) 2013-11-29
CN102471280B (zh) 2014-08-06
CA2767096A1 (fr) 2011-01-06
HK1169387A1 (en) 2013-01-25
ZA201200027B (en) 2013-03-27
EA020364B1 (ru) 2014-10-30
MA33500B1 (fr) 2012-08-01
US8367715B2 (en) 2013-02-05
MY155829A (en) 2015-12-15
CO6480992A2 (es) 2012-07-16
ECSP12011569A (es) 2012-02-29
WO2011001122A2 (fr) 2011-01-06
UA106500C2 (uk) 2014-09-10
FR2947546A1 (fr) 2011-01-07
KR20120037967A (ko) 2012-04-20
JP2012531466A (ja) 2012-12-10
TWI471312B (zh) 2015-02-01
ECSP12011659A (es) 2012-03-30
BR112012000104A2 (pt) 2016-03-15
AR077371A1 (es) 2011-08-24
MX2012000267A (es) 2012-04-30
IL217300A0 (en) 2012-02-29
AU2010267824A1 (en) 2012-02-16
UY32757A (es) 2011-01-31
TW201107298A (en) 2011-03-01
JP5680640B2 (ja) 2015-03-04
FR2947546B1 (fr) 2011-07-01
CL2012000013A1 (es) 2012-09-14
EP2448924B1 (fr) 2013-09-04
CN102471280A (zh) 2012-05-23
EP2448924A2 (fr) 2012-05-09
US20120270918A1 (en) 2012-10-25
EA201270128A1 (ru) 2012-07-30
PE20120917A1 (es) 2012-08-17
NI201200001A (es) 2012-03-30
TN2011000658A1 (fr) 2013-05-24

Similar Documents

Publication Publication Date Title
BRPI0922453A2 (pt) roupa íntima feminina
CL2012002979A1 (es) Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona.
LT3202460T (lt) Arilmetoksi izoindolino dariniai ir kompozicijos, apimantys ir jų panaudojimo būdus
LT2616102T (lt) Provaistas, apimantis eksendino-linkerio konjugatą
PT3026316T (pt) Colar de aperto articulado
BRPI1008955A2 (pt) Terapia de combinação com derivados de tiocolchicina.
BRPI1011527A2 (pt) derivados de triazina substituídos com ureidofenil e suas aplicações terapêuticas.
BR112012015868A2 (pt) derivados de imidazolidinadiona
EP2654422A4 (en) BICYCLO [3.2.1] OCTYLAMID DERIVATIVES AND THEIR USE
BRPI1008899A2 (pt) derivados 3,3´-espiroindolinona como agentes anticâncer
BRPI1016117A8 (pt) derivados de isoxazol-isoxazol e isoxazol-isotiazol.
MX347855B (es) Derivados de anilina, su preparación y su aplicación terapéutica.
EP2433616A4 (en) COSMETIC PREPARATION
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
BR112012016923A2 (pt) Derivados de pirazol
BRPI0914063A2 (pt) composição de xampu concentrado
BR112012014770A2 (pt) derivados de etinila
DK2442870T3 (da) Pyrazinooxazepin-derivater.
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
BRPI1016192A2 (pt) derivados de soxazol.
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
BRPI1008674A2 (pt) Métodos de redução do desenvolvimento de pragas resistentes.
CL2009001973S1 (es) Mostrador.
BR112012014459A2 (pt) derivados de pirrolidina.
TR200900882A2 (tr) Tadı ve kokusu maskelenmiş, bıyoyararlanımı yüksek farmasotık bileşimler.